Industry Focus

Latest Episodes:

CG: Where Food and Technology Meet Apr 02, 2019

Show notes

McDonald's invests in its customer experience and Whole Foods is lowering prices (again). On this week’s episode of Industry Focus: Consumer Goods host Jason Moser and Fool.com contributor Asit Sharma discuss how the fast-food giant is leaning on technology as well as Amazon's long-term strategy with Whole Foods. Plus Jason chats with Aaron Timmons to learn more about his career with Amazon in a new installment of Between Two Fools.

Check out more of our content here:

Financials: A Socially-Responsible Bank and Wells Fargo’s CEO Search Apr 01, 2019

Show notes

In this episode of Industry Focus: Financials, host Jason Moser sits down with Amalgamated Bank (NASDAQ: AMAL) CEO Keith Mestrich to talk about the opportunities and challenges of operating a smaller and socially-responsible bank in the modern financial landscape. Plus, Fool.com contributor Matt Frankel, CFP discusses what Wells Fargo (NYSE: WFC) CEO Tim Sloan’s abrupt departure could mean for the bank and its investors. And, you’ll hear which two stocks we’re watching this week.

Check out more of our content here:

Thanks to Grammarly for supporting The Motley Fool. For 20% off a Grammarly premium account, go to http://www.Grammarly.com/Fool.

Tech: Interested in Pinterest? Mar 29, 2019

Show notes

Another unicorn is going public! We take a look at Pinterest's prospectus and explain how the social media company has turned DIY pics into a $12B business.

Stocks: PINS, FB, GOOG, GOOGL

Check out more of our content here:

Energy: A Year in Steel Tariffs Mar 28, 2019

Show notes

On March 8, 2018, the United States enacted 25% tariffs on imported steel. A year later, have those tariffs accomplished what they set out to do? Motley Fool Contributor Jason Hall and Industry Focus host Nick Sciple answer that question and share their favorite steel investment on this week’s episode.

Healthcare: Is Biogen A Beat-Up Bargain? And Is Bristol-Myers' Mega-Merger On the Rocks? Mar 27, 2019

Show notes

Biogen's shares fell 30% because it's bailing on a once-promising Alzheimer's disease drug, but it might not be a bargain worth buying yet. Also, why a shareholder revolt could cause Bristol-Myers and Celgene's merger to fall apart.

Check out more of our content here:

Consumer Goods: Amazon Kicks out the CRaP, CVS Gets Into CBD Mar 26, 2019

Show notes

Amazon has increased its focus on profitability and that means getting rid of items where it “can’t realized a profit” or CRaP as the company unofficially calls them. Host Shannon Jones and Fool Contributor Daniel Kline also discuss whether CVS selling CBD products fits its image as a company focused on health.

Check out more of our content here:

Financials: The Fed, an Interview With Sallie Krawcheck, and Stocks We’re Watching Mar 25, 2019

Show notes

In the latest edition of our Between Two Fools interview series, host Jason Moser sits down with Ellevest CEO and co-founder Sallie Krawckeck. Then, Fool.com contributor Matt Frankel, CFP tells investors what they need to know about the latest Federal Reserve meeting and why bank stocks have been dropping ever since. Finally, you’ll hear which two stocks are on our watch lists this week.

Check out more of our content here:

Tech: ETFs Mar 22, 2019

Show notes

Today we talk about a topic we've never covered before -- ETFs!

Exchange-traded Funds are a great way for investors to get instant exposure to a basket of companies, and there are plenty of tech funds that have put up big returns over the past few years. We run through some solid options, and explain the difference between ETFs and mutual funds.

Tickers: ETFMG, HACK, ARKW, FDN, VGT, XLK

Check out more of our content here:

Energy: Is Graco a Great Co.? Mar 21, 2019

Show notes

Sometimes great companies are found in under-the-radar places. Graco is one of those companies. You probably haven’t heard of it (I thought it made baby strollers before doing my research), but this maker of industrial fluid and coating machinery has trounced Mr. Market over the past 25 years. Motley Fool Senior Analyst John Rotonti joins the podcast to discuss why this underfollowed company is an attractive investment today.

Stocks Mentioned: GGG, SHW

Check out more of our content here:

Healthcare: How To Build A Better Biotech Portfolio Mar 20, 2019

Show notes

Fool's have questions, we've got answers! In today's show we offer tips on what to look for before buying clinical-stage and commercial-stage biotech stocks, including 5 checklist items you ought to know.

Check out more of our content here:

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected

Our TOPPODCAST Picks

Follow Us

Stay Connected

Industry Focus

Related Podcasts

1

2

3

4

5

6